Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1097
https://www.valueinhealthjournal.com/article/S1098-3015(14)03027-7/fulltext
Title :
Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03027-7&doi=10.1016/j.jval.2014.08.1097
First page :
A431
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
599